Few & Far Between: Conversations from the Front Lines of Drug Development

Episode 29: Mika Newton, CEO at XCures


Listen Later

"We work with hundreds of patients a month, helping them understand their own medical history and then tracking what happens to them in the future and providing them and their physicians with decision support and alternative thinking about ways to treat their cancer." Mika Newton, CEO at xCures

Biorasi welcomes Mika Newton to the Few & Far Between podcast to examine how the connection between AI and oncology leads to a more patient-centric world.

...more
View all episodesView all episodes
Download on the App Store

Few & Far Between: Conversations from the Front Lines of Drug DevelopmentBy Chris O'Brien

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

View all
This American Life by This American Life

This American Life

90,400 Listeners

The Daily by The New York Times

The Daily

111,059 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

17 Listeners

The BioCentury Show by BioCentury

The BioCentury Show

11 Listeners